Ulipristal acetate: a guide to its use in uterine fibroids
- First Online:
- 72 Downloads
Oral ulipristal acetate (Esmya™), a selective progesterone-receptor modulator, is an effective and well tolerated option for the pre-operative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age. It is associated with rapid control of excessive uterine bleeding and sustained reductions in uterine fibroid volume.
- 5.Esmya 5 mg tablets (ulipristal acetate): summary of product characteristics. London: European Medicines Agency, 2012 Mar 15Google Scholar
- 7.Chabbert-Buffet N, Pintiaux-Kairis A, Bouchard P. Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial. J Clin Endocrinol Metab 2007 Sep; 92 (9): 3582–9PubMedCrossRefGoogle Scholar